| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0005 |